Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by TRIM32 is a member of the tripartite motif (TRIM) family. Additionally we are shipping TRIM32 Proteins (7) and many more products for this protein.
Showing 10 out of 51 products:
Human Monoclonal TRIM32 Primary Antibody for IF, RNAi - ABIN524889
Schwamborn, Berezikov, Knoblich: The TRIM-NHL protein TRIM32 activates microRNAs and prevents self-renewal in mouse neural progenitors. in Cell 2009
Show all 5 references for ABIN524889
Cow (Bovine) Polyclonal TRIM32 Primary Antibody for WB - ABIN2780865
Chiang, Beck, Yen, Tayeh, Scheetz, Swiderski, Nishimura, Braun, Kim, Huang, Elbedour, Carmi, Slusarski, Casavant, Stone, Sheffield: Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11). in Proceedings of the National Academy of Sciences of the United States of America 2006
Show all 3 references for ABIN2780865
Human Polyclonal TRIM32 Primary Antibody for ELISA, WB - ABIN564975
Sato, Okumura, Iguchi, Ariga, Hatakeyama: TRIM32 promotes retinoic acid receptor ?-mediated differentiation in human promyelogenous leukemic cell line HL60. in Biochemical and biophysical research communications 2012
Results suggest that Salmonella effector SseK3 binding to host tripartite motif-containing 32 protein (TRIM32) in the inhibition of nuclear factor kappa B (NF-kappaB (show NFKB1 Antibodies)) activation: [SseK3]
TRIM32 represents a model of intrinsic immunity, in which a host protein directly senses and counters viral infection in a species specific fashion by directly limiting viral replication
Data indicate that variants in tripartite motif-containing 32 protein (TRIM32) in two patients presenting nonspecific limb-girdle muscular dystrophy type 2H (LGMD2H) were identified by using high-throughput variants screening techniques.
TRIM32, an E3 ubiquitin ligase (show MUL1 Antibodies), promotes HIV reactivation from latency by directly modifying IkappaBalpha (show NFKBIA Antibodies)
Identification of TRIM32 as a novel p53 target and as a novel negative regulator for p53.
Trim32 is a positive regulator of ACD (show ACD Antibodies) that acts against MYCN (show MYCN Antibodies) and should be considered as a tumor-suppressor candidate
Deletions near the 3' terminus of ASTN2 (show ASTN2 Antibodies), a subset of these deletions also includes TRIM32, are significantly enriched in neurodevelopmental disorder subjects.
BBS11 promotes accumulation of NPHP7 (show GLIS2 Antibodies), changing the properties of NPHP7 (show GLIS2 Antibodies). TRIM32 Modulates the Transcriptional Activities of Glis2 (show GLIS2 Antibodies)
a novel connection between ubiquitylation and phosphorylation pathways, which could modulate a variety of cell events by stimulating the formation of the 14-3-3 (show YWHAQ Antibodies)-TRIM32 signaling complex.
TRIM32 assembles polyubiquitin chains as a Ubc5-linked thioester intermediate.
In summary, the data presented here reveal that TRIM32 directly regulates at least two of the four Yamanaka Factors (cMyc (show MYC Antibodies) and Oct4 (show POU5F1 Antibodies)), to modulate cell fate transitions.
NDRG2 (show NDRG2 Antibodies) accumulated in skeletal muscle and myoblasts in the absence of TRIM32. NDRG2 (show NDRG2 Antibodies) overexpression in myoblasts led to reduced cell proliferation and delayed cell cycle withdrawal during differentiation.
TRIM32 overexpression promotes cell oncogenic transformation and tumorigenesis in mice in a largely p53 (show TP53 Antibodies)-dependent manner.
Data show that RNA helicase DDX6 (show DDX6 Antibodies) colocalizes with ubiquitin-protein ligase (show UBE2K Antibodies) TRIM32 in neural stem cells and neurons and that it increases the activity of microRNA Let-7a.
TRIM32 plays important roles in regulation of hyperactivities and positively regulates the development of anxiety and depression disorders induced by chronic stress.
The results highlight the function of the cell fate-determinant TRIM32 for a balanced activity of the adult neurogenesis process.
Trim32 reduces PI3K-Akt (show AKT1 Antibodies)-FoxO (show FOXO3 Antibodies) signaling in normal and atrophying muscle by promoting plakoglobin (show JUP Antibodies)-PI3K dissociation.
TRIM32 physically interacts with TAp73 (show TP73 Antibodies) and promotes its ubiquitination and degradation while TAp73 (show TP73 Antibodies) regulates TRIM32 gene expression.
The protein encoded by this gene is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies. The protein has also been localized to the nucleus, where it interacts with the activation domain of the HIV-1 Tat protein. The Tat protein activates transcription of HIV-1 genes.
E3 ubiquitin-protein ligase TRIM32
, tripartite motif-containing 32
, TAT-interactive protein, 72-KD
, tripartite motif containing 32
, 72 kDa Tat-interacting protein
, tripartite motif-containing protein 32
, zinc finger protein HT2A
, zinc-finger protein HT2A
, bM468K2.2 (tripartite motif protein 32)
, tripartite motif protein 32
, zinc finger protein 117